Update: Influenza activity-United States, September 28, 2014–February 21, 2015

Morbidity and Mortality Weekly Report

Volumn 64, Issue 8, 2015, Pages 206-212

  D’Mello, Tiffany ^a   Brammer, Lynnette ^a   Blanton, Lenee ^a   Kniss, Krista ^a   Smith, Sophie ^a   Mustaquim, Desiree ^a   Steffens, Craig ^a   Dhara, Rosaline ^a   Cohen, Jessica ^a   Chaves, Sandra S ^a   Finelli, Lyn ^a   Bresee, Joseph ^a   Wallis, Teresa ^a   Xu, Xiyan ^a   Elal, Anwar Isa Abd ^a   Gubareva, Larisa ^a   Wentworth, David ^a   Villanueva, Julie ^a   Katz, Jackie ^a   Jernigan, Daniel ^a  

^a NATIONAL CENTER FOR IMMUNIZATION AND RESPIRATORY DISEASES   (United States)

^b Epidemiology   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

INFLUENZA VACCINE;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; ANTIVIRAL RESISTANCE; CAUSE OF DEATH; CHEMICALLY INDUCED; CHILD; CLASSIFICATION; COMORBIDITY; FEMALE; GENETICS; HEALTH SURVEY; HOSPITALIZATION; HUMAN; IMMUNOLOGY; INFANT; INFANT MORTALITY; INFLUENZA VIRUS A H1N1; INFLUENZA VIRUS A H3N2; INFLUENZA VIRUS B; INFLUENZA, HUMAN; ISOLATION AND PURIFICATION; MALE; MIDDLE AGED; OUTPATIENT; PNEUMONIA; PREGNANCY; PRESCHOOL CHILD; SEASON; STATISTICS AND NUMERICAL DATA; SURVIVAL RATE; TRENDS; UNITED STATES; YOUNG ADULT;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; CAUSE OF DEATH; CHILD; CHILD, PRESCHOOL; COMORBIDITY; DRUG RESISTANCE, VIRAL; FEMALE; HOSPITALIZATION; HUMANS; INFANT; INFANT MORTALITY; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA A VIRUS, H3N2 SUBTYPE; INFLUENZA B VIRUS; INFLUENZA VACCINES; INFLUENZA, HUMAN; MALE; MIDDLE AGED; OUTPATIENTS; PNEUMONIA; POPULATION SURVEILLANCE; PREGNANCY; SEASONS; SURVIVAL RATE; UNITED STATES; YOUNG ADULT;

EID: 84926640454     PISSN: 01492195     EISSN: 1545861X     Source Type: Journal    
DOI: None     Document Type: Note

References (9)

1. Flannery B, Clippard J, Zimmerman RK, et al. Early estimates of seasonal influenza vaccine effectiveness-United States, January 2015. MMWR Morb Mortal Wkly Rep 2015;64:10–5.
2. Rolfes M, Blanton L, Brammer L, et al. Update: influenza activity—United States, September 28–December 6, 2014. MMWR Morb Mortal Wkly Rep 2014;63:1189–94.
3. CDC. FluView interactive. Available at http://www.cdc.gov/flu/weekly/fluviewinteractive.htm.
4. Thompson WW, Shay DK, Weintraub E, et al. Influenza-associated hospitalizations in the United States. JAMA 2004;292:1333–40.
5. CDC. Estimates of deaths associated with seasonal influenza—United States, 1976-2007. MMWR 2010;59:1057–62.
6. CDC. Health advisory regarding the potential for circulation of drifted influenza A (H3N2) viruses. Available at http://emergency.cdc.gov/HAN/ han00374.asp.
7. CDC. CDC presents updated estimates of flu vaccine effectiveness for the 2014–2015 season. Available at http://www.cdc.gov/flu/news/updated-vaccine-effectiveness-2014-15.htm.
8. CDC. Antiviral agents for the treatment and chemoprophylaxis of influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Morb Mortal Wkly Rep 2011;60 (No. RR-1).
9. Dobson J, Whitley RJ, Pocock S, Monto AS. Oseltamivir treatment for influenza in adults: a meta-analysis of randomised controlled trials. Lancet 2015; January 30 [Epub ahead of print].